Filters

See more specimen types...

Other countries

Results: 1 to 17 of 17

Tests names and labsConditionsGenes and analytesMethods

CentoColon extended panel

Centogene AG - the Rare Disease Company
Germany
1917
  • C Sequence analysis of the entire coding region

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Colorectal Cancer Predisposition via the POLD1 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Prostate Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ovarian Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Endometrial Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5814
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHOP Comprehensive Hereditary Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
92128
  • C Sequence analysis of the entire coding region

Hereditary Colorectal and Gastrointestinal Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
3523
  • S Mutation scanning of the entire coding region

Focus Cancer Panel - 40 Genes

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5640
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer Panel

Invitae
United States
13979
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Common Hereditary Cancers Panel

Invitae
United States
7642
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

POLD1

Medizinisch Genetisches Zentrum München MGZ München
Germany
21
  • C Sequence analysis of the entire coding region

POLD1

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Colorectal Cancer Panel

Invitae
United States
3223
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer NGS Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
256112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 17 of 17

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.